Alkermes (ALKS) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Alkermes (ALKS) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.34 Bn | 625.58 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn | 5.45% |
| 3 | Merck | 366.20 Bn | 359.06 Bn | 12.21 Bn | 5.00% |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | -0.43% |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 2.85% |
| 6 | Sanofi | 52.41 Bn | 45.03 Bn | 10.79 Bn | 3.06% |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 8 | Incyte | 25.52 Bn | 20.98 Bn | 1.57 Bn | -1.81% |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn | 27.15% |
| 10 | Alkermes | 7.56 Bn | 6.91 Bn | 397.90 Mn | -12.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.32% |
| Mar 31, 2026 | -11.76% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -8.87% |
| Jun 30, 2025 | -10.79% |
| Mar 31, 2025 | -11.44% |
| Dec 31, 2024 | -12.62% |
| Sep 30, 2024 | -12.85% |
| Jun 30, 2024 | -13.48% |
| Mar 31, 2024 | -13.44% |
| Dec 31, 2023 | -13.45% |
| Sep 30, 2023 | -2.67% |
| Jun 30, 2023 | -3.63% |
| Mar 31, 2023 | -3.96% |
| Dec 31, 2022 | -14.94% |
| Sep 30, 2022 | -1.49% |
| Jun 30, 2022 | 1.10% |
| Mar 31, 2022 | 1.71% |
| Dec 31, 2021 | 3.23% |
| Sep 30, 2021 | 3.97% |